TNXA and deep vein thrombosis: Malinoski et al., reported that, despite similar characteristics (e.g., age, BMI, disease severity, etc.), patients with anti-Xa activity ≤ 0.1 IU/mL had significantly higher (37% vs. 11%) risk of DVT than patients with higher anti-Xa factor activity.